The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Kronos Bio Inc shares valued at $478,843 were purchased by BISCHOFBERGER NORBERT W on Jun 27 ’24. At $1.17 per share, BISCHOFBERGER NORBERT W acquired 410,848 shares. The insider’s holdings grew to 10,597,468 shares worth approximately $7.52 million following the completion of this transaction.
Also, BISCHOFBERGER NORBERT W purchased 204,670 shares, netting a total of over 254,957 in proceeds. Following the buying of shares at $1.25 each, the insider now holds 10,802,138 shares.
Before that, BISCHOFBERGER NORBERT W had added 1,378,901 shares to its account. In a trade valued at $1,208,469, the PRESIDENT & CEO bought Kronos Bio Inc shares for $0.88 each. Upon closing the transaction, the insider’s holdings increased to 1,378,901 shares, worth approximately $4.08 million.
As published in a research note from TD Cowen on November 14, 2024, Kronos Bio Inc [KRON] has been rated down from a Buy to a Hold. Analysts at Piper Sandler downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in mid November. As of September 14, 2022, Berenberg has initiated its “Buy” rating for KRON.
Analyzing KRON Stock Performance
During the last five days, there has been a drop of approximately -17.03%. Over the course of the year, Kronos Bio Inc shares have dropped approximately -24.80%. Shares of the company reached a 52-week high of $1.0900 on 01/23/25 and a 52-week low of $0.6700 on 05/01/25. A 50-day SMA is recorded $0.8842, while a 200-day SMA reached $0.9745.
Support And Resistance Levels for Kronos Bio Inc (KRON)
According to the 24-hour chart, there is a support level at 0.6763, which, if violated, would cause prices to drop to 0.6381. In the upper region, resistance lies at 0.7463. The next price resistance is at 0.7781. RSI (Relative Strength Index) is 30.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0245, which suggests the price will decrease in the coming days. Percent R is at 83.25%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Kronos Bio Inc (KRON)?
On June 24, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $35.
